Park Ha Biological Technology publishes MD&A for six months ended April 30, 2026 - BYAH News | RalliesPark Ha Biological Technology publishes MD&A for six months ended April 30, 2026
B
BYAH• MD&A highlights for six months ended April 30, 2026
- Park Ha Biological Technology published its MD&A for the six months ended April 30, 2026, showing revenue of $1,257,689, up 1%.
- Revenue mix shifted toward product sales at 57% from 33%, while franchise fees fell to 43% from 67%.
- Product sales rose 77% to $716,105, driven by higher non-franchise sales of $600,022, up 188%.
- Franchise-fee revenue dropped 35% to $541,584 as franchisees declined to 21 from 39; the model shifted to tighter admission standards.
- Net loss narrowed to $918,282 from $19.84 million; cash fell to $627,851 from $3.79 million, reflecting $5.02 million in short-term investments.
•
